Defence Therapeutics Inc
CNSX:DTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
A
|
Abbott Laboratories
XBER:ABL
|
US |
|
H
|
Hayasa Metals Inc
OTC:HAYAF
|
CA |
|
Jetblack Corp
OTC:JTBK
|
US |
|
R
|
Rotshtein Realestate Ltd
TASE:ROTS
|
IL |
|
E
|
Eikon Therapeutics Inc
NASDAQ:EIKN
|
US |
|
Powercell Sweden AB (publ)
OTC:PCELF
|
SE |
Profitability Summary
Defence Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Defence Therapeutics Inc
Margins Comparison
Defence Therapeutics Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| CA |
D
|
Defence Therapeutics Inc
CNSX:DTC
|
32.1m CAD |
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD |
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR |
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.3B USD |
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
302.3B CNY |
Loading...
|
Loading...
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
24.7B USD |
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
22.5B USD |
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
19.7B USD |
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
19.7B USD |
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
18.6B USD |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Defence Therapeutics Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| CA |
D
|
Defence Therapeutics Inc
CNSX:DTC
|
32.1m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
302.3B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
24.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
22.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
19.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
19.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
18.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
